High-dose versus low-dose inhaled levodopa (CVT-301) in patients with Parkinson disease for the treatment of OFF episodes: a meta-analysis of randomized controlled trials.
Zeya YanWei WangXinyu TaoWei ChengGang ZuoZhouqing ChenZhong WangGang ChenPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2022)
High doses CVT-301 can improve the motor function of the patient to some extent. There seems no risk of increasing adverse reactions.